CRBU Research and Charts

CRBU - Caribou Biosciences Inc Ordinary Shares (Healthcare: Biotechnology)

Projected Earnings Date: 0000-02-29 (Delayed quote data 2025-07-11)

Last 1.63	Change ⇓ -0.12 (-6.86%)	Volume 1,157,017
	Open 1.71	High 1.72	Low 1.62

8EMA (Daily) 1.51	40EMA (Daily) 1.24	50EMA (Daily) 1.21	STO (Daily) 86.380	MACD Hist (Daily) 0.067
8EMA (Weekly) 1.289	40EMA (Weekly) 1.53	50EMA (Weekly) 1.75	STO (Weekly) 83.499	MACD Hist (Weekly) 0.237


Company Profile
Caribou Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.